---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-233794"
form_type: "8-K"
ticker: "NUVB"
cik: "0001811063"
company_name: "Nuvation Bio Inc."
filed_at: "2024-10-07T23:59:59+00:00"
generated_at: "2026-05-30T19:25:20.700084+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Nuvation Bio appoints Philippe Sauvage as CFO effective October 7, 2024

## Summary
- Philippe Sauvage appointed CFO; previously SVP Global Head of Operations & Access at Sanofi (2020-2024).
- Initial annual base salary of $510,000; annual discretionary bonus up to 45% of base.
- Option award for 750,000 shares; vests 1/4 on one-year anniversary, then monthly vesting.
- Severance: 12 months base salary plus COBRA reimbursement; change-in-control double trigger with full equity acceleration.
- No family relationships or material transactions with directors or officers disclosed.

## SEC filing metadata
- accession: 0001193125-24-233794
- form_type: 8-K
- ticker: NUVB
- cik: 0001811063
- company_name: Nuvation Bio Inc.
- filed_at: 2024-10-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1811063/000119312524233794/0001193125-24-233794-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1811063/000119312524233794/d787897d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-233794
- JSON: https://secwatch.observer/filing/0001193125-24-233794.json
- Plain text: https://secwatch.observer/filing/0001193125-24-233794.txt

## Key facts
- Executive change
  Philippe Sauvage was appointed as Chief Financial Officer at Nuvation Bio Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: Effective October 7, 2024 (the “Appointment Date”), the Board of Nuvation Bio Inc. (the “Company”) appointed Philippe Sauvage as the Company’s Chief Financial Officer and Principal Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1811063/000119312524233794/0001193125-24-233794-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.